Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Diabetes Testing Program Market Insights, Forecast to 2030
Global Diabetes Testing Program Market Insights, Forecast to 2030
Industry: Medical Devices & Consumables
Published Date: 2024-03-20
Pages: 197 Pages
Report ld: 2655313
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Diabetes Testing Program market is projected to grow from US$ 2,504.20 million in 2024 to US$ 3,872.15 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.53% during the forecast period.
The United States & Canada market for Diabetes Testing Program is estimated to increase from $ 503.02 million in 2024 to reach $ 769.48 million by 2030, at a CAGR of 7.34% during the forecast period of 2025 through 2030.
The China market for Diabetes Testing Program is estimated to increase from $ 842.84 million in 2024 to reach $ 1,337.16 million by 2030, at a CAGR of 8.00% during the forecast period of 2025 through 2030.
The Europe market for Diabetes Testing Program is estimated to increase from $ 312.03 million in 2024 to reach $ 447.37 million by 2030, at a CAGR of 6.19% during the forecast period of 2025 through 2030.
The global key manufacturers of Diabetes Testing Program include Abbott Laboratories, Roche, Siemens, LifeScan, Bio-Rad Laboratories, etc. In 2023, the global top five players had a share approximately 64.41% in terms of revenue.
Report Includes
This report presents an overview of global market for Diabetes Testing Program, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Diabetes Testing Program, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Diabetes Testing Program, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Diabetes Testing Program sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Diabetes Testing Program market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Diabetes Testing Program sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Roche, LifeScan, Abbott Laboratories, Ascensia, Arkray, I-SENS, Omron, Braun, and Siemens, etc.
MARKET SEGMENTATION
By Company
- Abbott Laboratories
- Roche
- Siemens
- LifeScan
- Bio-Rad Laboratories
- Sinocare
- Tosoh
- Ascensia
- Danaher Corporation
- Trinity Biotech
- Acon Biotech
- Terumo
- Arkray
- HUMAN Diagnostics
- Braun
- I-SENS
- Omron
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- HbA1c Test
- Finger-prick Test
Segment by Application
- Medical Diagnosis
- Home Test
- Lab Testing
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Diabetes Testing Program in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Diabetes Testing Program manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetes Testing Program sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 STUDY COVERAGE 1
1.1 Diabetes Testing Program Product Introduction 1
1.2 Market by Type 2
1.2.1 Global Diabetes Testing Program Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 2
1.2.2 HbA1c Test 4
1.2.3 Finger-prick Test 5
1.3 Market by Application 5
1.3.1 Global Diabetes Testing Program Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 6
1.3.2 Medical Diagnosis 7
1.3.3 Home Test 8
1.3.4 Lab Testing 8
1.4 Assumptions and Limitations 9
1.5 Study Objectives 10
1.6 Years Considered 11
2 EXECUTIVE SUMMARY 12
2.1 Global Diabetes Testing Program Revenue Estimates and Forecasts 2019-2030 12
2.2 Global Diabetes Testing Program Revenue by Region 13
2.2.1 Global Diabetes Testing Program Revenue by Region: 2019 VS 2023 VS 2030 13
2.2.2 Global Diabetes Testing Program Revenue by Region (2019-2024) 15
2.2.3 Global Diabetes Testing Program Revenue by Region (2025-2030) 16
2.2.4 Global Diabetes Testing Program Revenue Market Share by Region (2019-2030) 16
2.3 Global Diabetes Testing Program Sales Estimates and Forecasts 2019-2030 17
2.4 Global Diabetes Testing Program Sales by Region 18
2.4.1 Global Diabetes Testing Program Sales by Region: 2019 VS 2023 VS 2030 18
2.4.2 Global Diabetes Testing Program Sales by Region (2019-2024) 19
2.4.3 Global Diabetes Testing Program Sales by Region (2025-2030) 19
2.4.4 Global Diabetes Testing Program Sales Market Share by Region (2019-2030) 20
2.5 US & Canada 21
2.6 Europe 22
2.7 China 23
2.8 Asia (excluding China) 24
2.9 Middle East, Africa and Latin America 25
3 COMPETITION BY MANUFACTURERS 27
3.1 Global Diabetes Testing Program Sales by Manufacturers 27
3.1.1 Global Diabetes Testing Program Sales by Manufacturers (2019-2024) 27
3.1.2 Global Diabetes Testing Program Sales Market Share by Manufacturers (2019-2024) 28
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diabetes Testing Program in 2023 29
3.2 Global Diabetes Testing Program Revenue by Manufacturers 31
3.2.1 Global Diabetes Testing Program Revenue by Manufacturers (2019-2024) 31
3.2.2 Global Diabetes Testing Program Revenue Market Share by Manufacturers (2019-2024) 32
3.2.3 Global Top 10 and Top 5 Companies by Diabetes Testing Program Revenue in 2023 33
3.3 Global Key Players of Diabetes Testing Program, Industry Ranking, 2021 VS 2022 34
3.4 Global Diabetes Testing Program Sales Price by Manufacturers (2019-2024) 35
3.5 Analysis of Competitive Landscape 36
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 36
3.5.2 Global Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 37
3.6 Global Key Manufacturers of Diabetes Testing Program, Manufacturing Base Distribution and Headquarters 39
3.7 Global Key Manufacturers of Diabetes Testing Program, Product Offered 39
3.8 Global Key Manufacturers of Diabetes Testing Program, Date of Enter into This Industry 40
3.9 Mergers & Acquisitions, Expansion Plans 41
4 MARKET SIZE BY TYPE 43
4.1 Global Diabetes Testing Program Sales by Type 43
4.1.1 Global Diabetes Testing Program Historical Sales by Type (2019-2024) 43
4.1.2 Global Diabetes Testing Program Forecasted Sales by Type (2025-2030) 43
4.1.3 Global Diabetes Testing Program Sales Market Share by Type (2019-2030) 44
4.2 Global Diabetes Testing Program Revenue by Type 45
4.2.1 Global Diabetes Testing Program Historical Revenue by Type (2019-2024) 45
4.2.2 Global Diabetes Testing Program Forecasted Revenue by Type (2025-2030) 45
4.2.3 Global Diabetes Testing Program Revenue Market Share by Type (2019-2030) 45
4.3 Global Diabetes Testing Program Price by Type 46
4.3.1 Global Diabetes Testing Program Price by Type (2019-2024) 46
4.3.2 Global Diabetes Testing Program Price Forecast by Type (2025-2030) 47
5 MARKET SIZE BY APPLICATION 48
5.1 Global Diabetes Testing Program Sales by Application 48
5.1.1 Global Diabetes Testing Program Historical Sales by Application (2019-2024) 48
5.1.2 Global Diabetes Testing Program Forecasted Sales by Application (2025-2030) 48
5.1.3 Global Diabetes Testing Program Sales Market Share by Application (2019-2030) 49
5.2 Global Diabetes Testing Program Revenue by Application 50
5.2.1 Global Diabetes Testing Program Historical Revenue by Application (2019-2024) 50
5.2.2 Global Diabetes Testing Program Forecasted Revenue by Application (2025-2030) 50
5.2.3 Global Diabetes Testing Program Revenue Market Share by Application (2019-2030) 50
5.3 Global Diabetes Testing Program Price by Application 52
5.3.1 Global Diabetes Testing Program Price by Application (2019-2024) 52
5.3.2 Global Diabetes Testing Program Price Forecast by Application (2025-2030) 52
6 US & CANADA 53
6.1 US & Canada Diabetes Testing Program Market Size by Type 53
6.1.1 US & Canada Diabetes Testing Program Sales by Type (2019-2030) 53
6.1.2 US & Canada Diabetes Testing Program Revenue by Type (2019-2030) 54
6.2 US & Canada Diabetes Testing Program Market Size by Application 55
6.2.1 US & Canada Diabetes Testing Program Sales by Application (2019-2030) 55
6.2.2 US & Canada Diabetes Testing Program Revenue by Application (2019-2030) 56
6.3 US & Canada Diabetes Testing Program Market Size by Country 58
6.3.1 US & Canada Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030 58
6.3.2 US & Canada Diabetes Testing Program Revenue by Country (2019-2030) 58
6.3.3 US & Canada Diabetes Testing Program Sales by Country (2019-2030) 59
6.3.4 US 60
6.3.5 Canada 61
7 EUROPE 62
7.1 Europe Diabetes Testing Program Market Size by Type 62
7.1.1 Europe Diabetes Testing Program Sales by Type (2019-2030) 62
7.1.2 Europe Diabetes Testing Program Revenue by Type (2019-2030) 63
7.2 Europe Diabetes Testing Program Market Size by Application 64
7.2.1 Europe Diabetes Testing Program Sales by Application (2019-2030) 64
7.2.2 Europe Diabetes Testing Program Revenue by Application (2019-2030) 65
7.3 Europe Diabetes Testing Program Market Size by Country 66
7.3.1 Europe Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030 66
7.3.2 Europe Diabetes Testing Program Revenue by Country (2019-2030) 67
7.3.3 Europe Diabetes Testing Program Sales by Country (2019-2030) 68
7.3.4 Germany 70
7.3.5 France 70
7.3.6 U.K. 71
7.3.7 Italy 71
7.3.8 Russia 72
8 CHINA 73
8.1 China Diabetes Testing Program Market Size by Type 73
8.1.1 China Diabetes Testing Program Sales by Type (2019-2030) 73
8.1.2 China Diabetes Testing Program Revenue by Type (2019-2030) 74
8.2 China Diabetes Testing Program Market Size by Application 75
8.2.1 China Diabetes Testing Program Sales by Application (2019-2030) 75
8.2.2 China Diabetes Testing Program Revenue by Application (2019-2030) 76
9 ASIA (EXCLUDING CHINA) 78
9.1 Asia Diabetes Testing Program Market Size by Type 78
9.1.1 Asia Diabetes Testing Program Sales by Type (2019-2030) 78
9.1.2 Asia Diabetes Testing Program Revenue by Type (2019-2030) 79
9.2 Asia Diabetes Testing Program Market Size by Application 80
9.2.1 Asia Diabetes Testing Program Sales by Application (2019-2030) 80
9.2.2 Asia Diabetes Testing Program Revenue by Application (2019-2030) 81
9.3 Asia Diabetes Testing Program Market Size by Region 82
9.3.1 Asia Diabetes Testing Program Revenue by Region: 2019 VS 2023 VS 2030 82
9.3.2 Asia Diabetes Testing Program Revenue by Region (2019-2030) 82
9.3.3 Asia Diabetes Testing Program Sales by Region (2019-2030) 83
9.3.4 Japan 85
9.3.5 South Korea 85
9.3.6 Southeast Asia 86
9.3.7 India 86
9.3.8 Australia 87
10 MIDDLE EAST, AFRICA AND LATIN AMERICA 88
10.1 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Type 88
10.1.1 Middle East, Africa and Latin America Diabetes Testing Program Sales by Type (2019-2030) 88
10.1.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Type (2019-2030) 89
10.2 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Application 90
10.2.1 Middle East, Africa and Latin America Diabetes Testing Program Sales by Application (2019-2030) 90
10.2.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Application (2019-2030) 91
10.3 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Country 93
10.3.1 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030 93
10.3.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country (2019-2030) 93
10.3.3 Middle East, Africa and Latin America Diabetes Testing Program Sales by Country (2019-2030) 95
10.3.4 Brazil 96
10.3.5 Mexico 97
10.3.6 Turkey 97
10.3.7 Israel 98
10.3.8 GCC Countries 98
11 CORPORATE PROFILE 99
11.1 Abbott Laboratories 99
11.1.1 Abbott Laboratories Company Information 99
11.1.2 Abbott Laboratories Overview 99
11.1.3 Abbott Laboratories Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 100
11.1.4 Abbott Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 100
11.1.5 Abbott Laboratories Recent Developments 101
11.2 Roche 102
11.2.1 Roche Company Information 102
11.2.2 Roche Overview 102
11.2.3 Roche Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 103
11.2.4 Roche Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 103
11.2.5 Roche Recent Developments 105
11.3 Siemens 106
11.3.1 Siemens Company Information 106
11.3.2 Siemens Overview 106
11.3.3 Siemens Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 107
11.3.4 Siemens Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 108
11.3.5 Siemens Recent Developments 108
11.4 LifeScan 109
11.4.1 LifeScan Company Information 109
11.4.2 LifeScan Overview 110
11.4.3 LifeScan Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 110
11.5 Bio-Rad Laboratories 111
11.5.1 Bio-Rad Laboratories Company Information 112
11.5.2 Bio-Rad Laboratories Overview 112
11.5.3 Bio-Rad Laboratories Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 113
11.5.4 Bio-Rad Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 113
11.5.5 Bio-Rad Laboratories Recent Developments 114
11.6 Sinocare 114
11.6.1 Sinocare Company Information 114
11.6.2 Sinocare Overview 115
11.6.3 Sinocare Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 115
11.6.4 Sinocare Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 116
11.7 Tosoh 117
11.7.1 Tosoh Company Information 118
11.7.2 Tosoh Overview 118
11.7.3 Tosoh Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 119
11.7.4 Tosoh Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 120
11.7.5 Tosoh Recent Developments 120
11.8 Ascensia 121
11.8.1 Ascensia Company Information 121
11.8.2 Ascensia Overview 122
11.8.3 Ascensia Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 122
11.8.4 Ascensia Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 123
11.9 Danaher Corporation 124
11.9.1 Danaher Corporation Company Information 124
11.9.2 Danaher Corporation Overview 125
11.9.3 Danaher Corporation Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 126
11.9.4 Danaher Corporation Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 126
11.9.5 Danaher Corporation Recent Developments 127
11.10 Trinity Biotech 128
11.10.1 Trinity Biotech Company Information 128
11.10.2 Trinity Biotech Overview 128
11.10.3 Trinity Biotech Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 130
11.10.4 Trinity Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 130
11.10.5 Trinity Biotech Recent Developments 131
11.11 Acon Biotech 132
11.11.1 Acon Biotech Company Information 132
11.11.2 Acon Biotech Overview 132
11.11.3 Acon Biotech Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 133
11.11.4 Acon Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 133
11.12 Terumo 134
11.12.1 Terumo Company Information 135
11.12.2 Terumo Overview 135
11.12.3 Terumo Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 136
11.12.4 Terumo Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 137
11.12.5 Terumo Recent Developments 138
11.13 Arkray 139
11.13.1 Arkray Company Information 139
11.13.2 Arkray Overview 139
11.13.3 Arkray Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 140
11.13.4 Arkray Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 140
11.14 HUMAN Diagnostics 142
11.14.1 HUMAN Diagnostics Company Information 142
11.14.2 HUMAN Diagnostics Overview 142
11.14.3 HUMAN Diagnostics Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 143
11.14.4 HUMAN Diagnostics Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 143
11.15 Braun 144
11.15.1 Braun Company Information 144
11.15.2 Braun Overview 145
11.15.3 Braun Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 145
11.15.4 Braun Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 146
11.15.5 Braun Recent Developments 147
11.16 I-SENS 147
11.16.1 I-SENS Company Information 147
11.16.2 I-SENS Overview 148
11.16.3 I-SENS Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 148
11.16.4 I-SENS Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 148
11.16.5 I-SENS Recent Developments 149
11.17 Omron 150
11.17.1 Omron Company Information 150
11.17.2 Omron Overview 150
11.17.3 Omron Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024) 151
11.17.4 Omron Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 151
11.17.5 Omron Recent Developments 152
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 154
12.1 Diabetes Testing Program Industry Chain Analysis 154
12.2 Diabetes Testing Program Key Raw Materials 155
12.2.1 Key Raw Materials 155
12.2.2 Raw Materials Key Suppliers 155
12.3 Diabetes Testing Program Production Mode & Process 156
12.4 Diabetes Testing Program Sales and Marketing 157
12.4.1 Diabetes Testing Program Sales Channels 157
12.4.2 Diabetes Testing Program Distributors 157
12.5 Diabetes Testing Program Customers 158
13 DIABETES TESTING PROGRAM MARKET DYNAMICS 159
13.1.1 Diabetes Testing Program Industry Trends 159
13.1.2 Diabetes Testing Program Market Drivers 160
13.1.3 Diabetes Testing Program Market Challenges 161
13.1.4 Diabetes Testing Program Market Restraints 162
14 KEY FINDINGS IN THE GLOBAL DIABETES TESTING PROGRAM STUDY 163
15 APPENDIX 164
15.1 Research Methodology 164
15.1.1 Methodology/Research Approach 164
15.1.2 Data Source 167
15.2 Author Details 170
15.3 Disclaimer 170
TABLE OF FIGURES
List of Tables
Table 1. Global Diabetes Testing Program Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) 2
Table 2. Major Manufacturers of Finger-prick Test 5
Table 3. Global Diabetes Testing Program Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) 6
Table 4. Global Diabetes Testing Program Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) 14
Table 5. Global Diabetes Testing Program Revenue by Region (2019-2024) & (US$ Million) 15
Table 6. Global Diabetes Testing Program Revenue by Region (2025-2030) & (US$ Million) 16
Table 7. Global Diabetes Testing Program Revenue Market Share by Region (2019-2024) 16
Table 8. Global Diabetes Testing Program Revenue Market Share by Region (2025-2030) 17
Table 9. Global Diabetes Testing Program Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units) 18
Table 10. Global Diabetes Testing Program Sales by Region (2019-2024) & (K Units) 19
Table 11. Global Diabetes Testing Program Sales by Region (2025-2030) & (K Units) 19
Table 12. Global Diabetes Testing Program Sales Market Share by Region (2019-2024) 20
Table 13. Global Diabetes Testing Program Sales Market Share by Region (2025-2030) 20
Table 14. Global Diabetes Testing Program Sales by Manufacturers (2019-2024) & (K Units) 27
Table 15. Global Diabetes Testing Program Sales Share by Manufacturers (2019-2024) 28
Table 16. Global Diabetes Testing Program Revenue by Manufacturers (2019-2024) & (US$ Million) 31
Table 17. Global Diabetes Testing Program Revenue Market Share by Manufacturers (2019-2024) 32
Table 18. Global Key Players of Diabetes Testing Program, Industry Ranking, 2021 VS 2022 34
Table 19. Diabetes Testing Program Price by Manufacturers (2019-2024) & (US$/Unit) 35
Table 20. Global Diabetes Testing Program Manufacturers Market Concentration Ratio (CR5 and HHI) 37
Table 21. Global Diabetes Testing Program by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Testing Program as of 2023) 37
Table 22. Global Key Manufacturers of Diabetes Testing Program, Manufacturing Base Distribution and Headquarters 39
Table 23. Global Key Manufacturers of Diabetes Testing Program, Product Offered 40
Table 24. Global Key Manufacturers of Diabetes Testing Program, Date of Enter into This Industry 40
Table 25. Mergers & Acquisitions, Expansion Plans 41
Table 26. Global Diabetes Testing Program Sales by Type (2019-2024) & (K Units) 43
Table 27. Global Diabetes Testing Program Sales by Type (2025-2030) & (K Units) 43
Table 28. Global Diabetes Testing Program Sales Share by Type (2019-2024) 44
Table 29. Global Diabetes Testing Program Sales Share by Type (2025-2030) 44
Table 30. Global Diabetes Testing Program Revenue by Type (2019-2024) & (US$ Million) 45
Table 31. Global Diabetes Testing Program Revenue by Type (2025-2030) & (US$ Million) 45
Table 32. Global Diabetes Testing Program Revenue Share by Type (2019-2024) 45
Table 33. Global Diabetes Testing Program Revenue Share by Type (2025-2030) 46
Table 34. Diabetes Testing Program Price by Type (2019-2024) & (US$/Unit) 46
Table 35. Global Diabetes Testing Program Price Forecast by Type (2025-2030) & (US$/Unit) 47
Table 36. Global Diabetes Testing Program Sales by Application (2019-2024) & (K Units) 48
Table 37. Global Diabetes Testing Program Sales by Application (2025-2030) & (K Units) 48
Table 38. Global Diabetes Testing Program Sales Share by Application (2019-2024) 49
Table 39. Global Diabetes Testing Program Sales Share by Application (2025-2030) 49
Table 40. Global Diabetes Testing Program Revenue by Application (2019-2024) & (US$ Million) 50
Table 41. Global Diabetes Testing Program Revenue by Application (2025-2030) & (US$ Million) 50
Table 42. Global Diabetes Testing Program Revenue Share by Application (2019-2024) 50
Table 43. Global Diabetes Testing Program Revenue Share by Application (2025-2030) 51
Table 44. Diabetes Testing Program Price by Application (2019-2024) & (US$/Unit) 52
Table 45. Global Diabetes Testing Program Price Forecast by Application (2025-2030) & (US$/Unit) 52
Table 46. US & Canada Diabetes Testing Program Sales by Type (2019-2024) & (K Units) 53
Table 47. US & Canada Diabetes Testing Program Sales by Type (2025-2030) & (K Units) 53
Table 48. US & Canada Diabetes Testing Program Revenue by Type (2019-2024) & (US$ Million) 54
Table 49. US & Canada Diabetes Testing Program Revenue by Type (2025-2030) & (US$ Million) 54
Table 50. US & Canada Diabetes Testing Program Sales by Application (2019-2024) & (K Units) 55
Table 51. US & Canada Diabetes Testing Program Sales by Application (2025-2030) & (K Units) 55
Table 52. US & Canada Diabetes Testing Program Revenue by Application (2019-2024) & (US$ Million) 56
Table 53. US & Canada Diabetes Testing Program Revenue by Application (2025-2030) & (US$ Million) 57
Table 54. US & Canada Diabetes Testing Program Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) 58
Table 55. US & Canada Diabetes Testing Program Revenue by Country (2019-2024) & (US$ Million) 58
Table 56. US & Canada Diabetes Testing Program Revenue by Country (2025-2030) & (US$ Million) 58
Table 57. US & Canada Diabetes Testing Program Sales by Country (2019-2024) & (K Units) 59
Table 58. US & Canada Diabetes Testing Program Sales by Country (2025-2030) & (K Units) 59
Table 59. Europe Diabetes Testing Program Sales by Type (2019-2024) & (K Units) 62
Table 60. Europe Diabetes Testing Program Sales by Type (2025-2030) & (K Units) 62
Table 61. Europe Diabetes Testing Program Revenue by Type (2019-2024) & (US$ Million) 63
Table 62. Europe Diabetes Testing Program Revenue by Type (2025-2030) & (US$ Million) 63
Table 63. Europe Diabetes Testing Program Sales by Application (2019-2024) & (K Units) 64
Table 64. Europe Diabetes Testing Program Sales by Application (2025-2030) & (K Units) 64
Table 65. Europe Diabetes Testing Program Revenue by Application (2019-2024) & (US$ Million) 65
Table 66. Europe Diabetes Testing Program Revenue by Application (2025-2030) & (US$ Million) 65
Table 67. Europe Diabetes Testing Program Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) 66
Table 68. Europe Diabetes Testing Program Revenue by Country (2019-2024) & (US$ Million) 67
Table 69. Europe Diabetes Testing Program Revenue by Country (2025-2030) & (US$ Million) 67
Table 70. Europe Diabetes Testing Program Sales by Country (2019-2024) & (K Units) 68
Table 71. Europe Diabetes Testing Program Sales by Country (2025-2030) & (K Units) 68
Table 72. China Diabetes Testing Program Sales by Type (2019-2024) & (K Units) 73
Table 73. China Diabetes Testing Program Sales by Type (2025-2030) & (K Units) 73
Table 74. China Diabetes Testing Program Revenue by Type (2019-2024) & (US$ Million) 74
Table 75. China Diabetes Testing Program Revenue by Type (2025-2030) & (US$ Million) 74
Table 76. China Diabetes Testing Program Sales by Application (2019-2024) & (K Units) 75
Table 77. China Diabetes Testing Program Sales by Application (2025-2030) & (K Units) 75
Table 78. China Diabetes Testing Program Revenue by Application (2019-2024) & (US$ Million) 76
Table 79. China Diabetes Testing Program Revenue by Application (2025-2030) & (US$ Million) 76
Table 80. Asia Diabetes Testing Program Sales by Type (2019-2024) & (K Units) 78
Table 81. Asia Diabetes Testing Program Sales by Type (2025-2030) & (K Units) 78
Table 82. Asia Diabetes Testing Program Revenue by Type (2019-2024) & (US$ Million) 79
Table 83. Asia Diabetes Testing Program Revenue by Type (2025-2030) & (US$ Million) 79
Table 84. Asia Diabetes Testing Program Sales by Application (2019-2024) & (K Units) 80
Table 85. Asia Diabetes Testing Program Sales by Application (2025-2030) & (K Units) 80
Table 86. Asia Diabetes Testing Program Revenue by Application (2019-2024) & (US$ Million) 81
Table 87. Asia Diabetes Testing Program Revenue by Application (2025-2030) & (US$ Million) 81
Table 88. Asia Diabetes Testing Program Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) 82
Table 89. Asia Diabetes Testing Program Revenue by Region (2019-2024) & (US$ Million) 82
Table 90. Asia Diabetes Testing Program Revenue by Region (2025-2030) & (US$ Million) 83
Table 91. Asia Diabetes Testing Program Sales by Region (2019-2024) & (K Units) 83
Table 92. Asia Diabetes Testing Program Sales by Region (2025-2030) & (K Units) 84
Table 93. Middle East, Africa and Latin America Diabetes Testing Program Sales by Type (2019-2024) & (K Units) 88
Table 94. Middle East, Africa and Latin America Diabetes Testing Program Sales by Type (2025-2030) & (K Units) 88
Table 95. Middle East, Africa and Latin America Diabetes Testing Program Revenue by Type (2019-2024) & (US$ Million) 89
Table 96. Middle East, Africa and Latin America Diabetes Testing Program Revenue by Type (2025-2030) & (US$ Million) 89
Table 97. Middle East, Africa and Latin America Diabetes Testing Program Sales by Application (2019-2024) & (K Units) 90
Table 98. Middle East, Africa and Latin America Diabetes Testing Program Sales by Application (2025-2030) & (K Units) 91
Table 99. Middle East, Africa and Latin America Diabetes Testing Program Revenue by Application (2019-2024) & (US$ Million) 91
Table 100. Middle East, Africa and Latin America Diabetes Testing Program Revenue by Application (2025-2030) & (US$ Million) 92
Table 101. Middle East, Africa and Latin America Diabetes Testing Program Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) 93
Table 102. Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country (2019-2024) & (US$ Million) 93
Table 103. Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country (2025-2030) & (US$ Million) 94
Table 104. Middle East, Africa and Latin America Diabetes Testing Program Sales by Country (2019-2024) & (K Units) 95
Table 105. Middle East, Africa and Latin America Diabetes Testing Program Sales by Country (2025-2030) & (K Units) 95
Table 106. Abbott Laboratories Company Information 99
Table 107. Abbott Laboratories Description and Major Businesses 99
Table 108. Abbott Laboratories Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 100
Table 109. Abbott Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 100
Table 110. Abbott Laboratories Recent Developments 101
Table 111. Roche Company Information 102
Table 112. Roche Description and Major Businesses 102
Table 113. Roche Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 103
Table 114. Roche Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 103
Table 115. Roche Recent Developments 105
Table 116. Siemens Company Information 106
Table 117. Siemens Description and Major Businesses 106
Table 118. Siemens Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 107
Table 119. Siemens Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 108
Table 120. Siemens Recent Developments 108
Table 121. LifeScan Company Information 109
Table 122. LifeScan Description and Major Businesses 110
Table 123. LifeScan Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 110
Table 124. LifeScan Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 110
Table 125. Bio-Rad Laboratories Company Information 112
Table 126. Bio-Rad Laboratories Description and Major Businesses 112
Table 127. Bio-Rad Laboratories Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 113
Table 128. Bio-Rad Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 113
Table 129. Bio-Rad Laboratories Recent Developments 114
Table 130. Sinocare Company Information 114
Table 131. Sinocare Description and Major Businesses 115
Table 132. Sinocare Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 115
Table 133. Sinocare Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 116
Table 134. Tosoh Company Information 118
Table 135. Tosoh Description and Major Businesses 118
Table 136. Tosoh Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 119
Table 137. Tosoh Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 120
Table 138. Tosoh Recent Developments 120
Table 139. Ascensia Company Information 121
Table 140. Ascensia Description and Major Businesses 122
Table 141. Ascensia Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 122
Table 142. Ascensia Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 123
Table 143. Danaher Corporation Company Information 124
Table 144. Danaher Corporation Description and Major Businesses 125
Table 145. Danaher Corporation Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 126
Table 146. Danaher Corporation Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 126
Table 147. Danaher Corporation Recent Developments 127
Table 148. Trinity Biotech Company Information 128
Table 149. Trinity Biotech Description and Major Businesses 128
Table 150. Trinity Biotech Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 130
Table 151. Trinity Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 130
Table 152. Trinity Biotech Recent Developments 131
Table 153. Acon Biotech Company Information 132
Table 154. Acon Biotech Description and Major Businesses 132
Table 155. Acon Biotech Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 133
Table 156. Acon Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 133
Table 157. Terumo Company Information 135
Table 158. Terumo Description and Major Businesses 135
Table 159. Terumo Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 136
Table 160. Terumo Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 137
Table 161. Terumo Recent Developments 138
Table 162. Arkray Company Information 139
Table 163. Arkray Description and Major Businesses 139
Table 164. Arkray Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 140
Table 165. Arkray Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 140
Table 166. HUMAN Diagnostics Company Information 142
Table 167. HUMAN Diagnostics Description and Major Businesses 142
Table 168. HUMAN Diagnostics Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 143
Table 169. HUMAN Diagnostics Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 143
Table 170. Braun Company Information 144
Table 171. Braun Description and Major Businesses 145
Table 172. Braun Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 145
Table 173. Braun Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 146
Table 174. Braun Recent Developments 147
Table 175. I-SENS Company Information 147
Table 176. I-SENS Description and Major Businesses 148
Table 177. I-SENS Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 148
Table 178. I-SENS Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 148
Table 179. I-SENS Recent Developments 149
Table 180. Omron Company Information 150
Table 181. Omron Description and Major Businesses 150
Table 182. Omron Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) 151
Table 183. Omron Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications 151
Table 184. Omron Recent Developments 152
Table 185. Raw Materials Key Suppliers Lists 155
Table 186. Diabetes Testing Program Distributors List 157
Table 187. Diabetes Testing Program Customers List 158
Table 188. Diabetes Testing Program Market Trends 159
Table 189. Diabetes Testing Program Market Drivers 160
Table 190. Diabetes Testing Program Market Challenges 161
Table 191. Diabetes Testing Program Market Restraints 162
Table 192. Research Programs/Design for This Report 164
Table 193. Key Data Information from Secondary Sources 168
Table 194. Key Data Information from Primary Sources 168
List of Figures
Figure 1. Diabetes Testing Program Product Picture 1
Figure 2. Global Diabetes Testing Program Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) 2
Figure 3. Global Diabetes Testing Program Market Share by Type: 2023 & 2030 3
Figure 4. HbA1c Test Product Picture 4
Figure 5. Major Manufacturers of HbA1c Test 4
Figure 6. Finger-prick Test Product Picture 5
Figure 7. Global Diabetes Testing Program Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) 6
Figure 8. Global Diabetes Testing Program Market Share by Application: 2023 & 2030 7
Figure 9. Medical Diagnosis 8
Figure 10. Home Test 8
Figure 11. Lab Testing 9
Figure 12. Diabetes Testing Program Report Years Considered 11
Figure 13. Global Diabetes Testing Program Revenue, (US$ Million), 2019 VS 2023 VS 2030 12
Figure 14. Global Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 13
Figure 15. Global Diabetes Testing Program Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) 14
Figure 16. Global Diabetes Testing Program Revenue Market Share by Region in Percentage: 2023 Versus 2030 15
Figure 17. Global Diabetes Testing Program Revenue Market Share by Region (2019-2030) 17
Figure 18. Global Diabetes Testing Program Sales (2019-2030) & (K Units) 18
Figure 19. Global Diabetes Testing Program Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units) 19
Figure 20. Global Diabetes Testing Program Sales Market Share by Region (2019-2030) 21
Figure 21. US & Canada Diabetes Testing Program Sales YoY (2019-2030) & (K Units) 21
Figure 22. US & Canada Diabetes Testing Program Revenue YoY (2019-2030) & (US$ Million) 22
Figure 23. Europe Diabetes Testing Program Sales YoY (2019-2030) & (K Units) 22
Figure 24. Europe Diabetes Testing Program Revenue YoY (2019-2030) & (US$ Million) 23
Figure 25. China Diabetes Testing Program Sales YoY (2019-2030) & (K Units) 23
Figure 26. China Diabetes Testing Program Revenue YoY (2019-2030) & (US$ Million) 24
Figure 27. Asia (excluding China) Diabetes Testing Program Sales YoY (2019-2030) & (K Units) 24
Figure 28. Asia (excluding China) Diabetes Testing Program Revenue YoY (2019-2030) & (US$ Million) 25
Figure 29. Middle East, Africa and Latin America Diabetes Testing Program Sales YoY (2019-2030) & (K Units) 25
Figure 30. Middle East, Africa and Latin America Diabetes Testing Program Revenue YoY (2019-2030) & (US$ Million) 26
Figure 31. Global Diabetes Testing Program Sales Share by Manufacturers (2023) 29
Figure 32. The Diabetes Testing Program Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023 30
Figure 33. Global Diabetes Testing Program Revenue Share by Manufacturers (2023) 33
Figure 34. The Top 5 and 10 Largest Manufacturers of Diabetes Testing Program in the World: Market Share by Diabetes Testing Program Revenue in 2023 34
Figure 35. Global Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 38
Figure 36. Global Diabetes Testing Program Sales Market Share by Type (2019-2030) 44
Figure 37. Global Diabetes Testing Program Revenue Market Share by Type (2019-2030) 46
Figure 38. Global Diabetes Testing Program Sales Market Share by Application (2019-2030) 49
Figure 39. Global Diabetes Testing Program Revenue Market Share by Application (2019-2030) 51
Figure 40. US & Canada Diabetes Testing Program Sales Market Share by Type (2019-2030) 54
Figure 41. US & Canada Diabetes Testing Program Revenue Market Share by Type (2019-2030) 55
Figure 42. US & Canada Diabetes Testing Program Sales Market Share by Application (2019-2030) 56
Figure 43. US & Canada Diabetes Testing Program Revenue Market Share by Application (2019-2030) 57
Figure 44. US & Canada Diabetes Testing Program Revenue Share by Country (2019-2030) 59
Figure 45. US & Canada Diabetes Testing Program Sales Share by Country (2019-2030) 60
Figure 46. US Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 60
Figure 47. Canada Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 61
Figure 48. Europe Diabetes Testing Program Sales Market Share by Type (2019-2030) 62
Figure 49. Europe Diabetes Testing Program Revenue Market Share by Type (2019-2030) 63
Figure 50. Europe Diabetes Testing Program Sales Market Share by Application (2019-2030) 65
Figure 51. Europe Diabetes Testing Program Revenue Market Share by Application (2019-2030) 66
Figure 52. Europe Diabetes Testing Program Revenue Share by Country (2019-2030) 68
Figure 53. Europe Diabetes Testing Program Sales Share by Country (2019-2030) 69
Figure 54. Germany Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 70
Figure 55. France Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 70
Figure 56. U.K. Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 71
Figure 57. Italy Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 71
Figure 58. Russia Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 72
Figure 59. China Diabetes Testing Program Sales Market Share by Type (2019-2030) 73
Figure 60. China Diabetes Testing Program Revenue Market Share by Type (2019-2030) 74
Figure 61. China Diabetes Testing Program Sales Market Share by Application (2019-2030) 75
Figure 62. China Diabetes Testing Program Revenue Market Share by Application (2019-2030) 77
Figure 63. Asia Diabetes Testing Program Sales Market Share by Type (2019-2030) 78
Figure 64. Asia Diabetes Testing Program Revenue Market Share by Type (2019-2030) 79
Figure 65. Asia Diabetes Testing Program Sales Market Share by Application (2019-2030) 80
Figure 66. Asia Diabetes Testing Program Revenue Market Share by Application (2019-2030) 81
Figure 67. Asia Diabetes Testing Program Revenue Share by Region (2019-2030) 83
Figure 68. Asia Diabetes Testing Program Sales Share by Region (2019-2030) 84
Figure 69. Japan Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 85
Figure 70. South Korea Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 85
Figure 71. Southeast Asia Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 86
Figure 72. India Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 86
Figure 73. Australia Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 87
Figure 74. Middle East, Africa and Latin America Diabetes Testing Program Sales Market Share by Type (2019-2030) 89
Figure 75. Middle East, Africa and Latin America Diabetes Testing Program Revenue Market Share by Type (2019-2030) 90
Figure 76. Middle East, Africa and Latin America Diabetes Testing Program Sales Market Share by Application (2019-2030) 91
Figure 77. Middle East, Africa and Latin America Diabetes Testing Program Revenue Market Share by Application (2019-2030) 92
Figure 78. Middle East, Africa and Latin America Diabetes Testing Program Revenue Share by Country (2019-2030) 94
Figure 79. Middle East, Africa and Latin America Diabetes Testing Program Sales Share by Country (2019-2030) 96
Figure 80. Brazil Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 96
Figure 81. Mexico Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 97
Figure 82. Turkey Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 97
Figure 83. Israel Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 98
Figure 84. GCC Countries Diabetes Testing Program Revenue (2019-2030) & (US$ Million) 98
Figure 85. Diabetes Testing Program Value Chain 154
Figure 86. Diabetes Testing Program Production Process 156
Figure 87. Channels of Distribution (Direct Vs Distribution) 157
Figure 88. Bottom-up and Top-down Approaches for This Report 166
Figure 89. Data Triangulation 167
Figure 90. Key Executives Interviewed 169
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Diabetes Testing Program market?
The top companies in the global Diabetes Testing Program market are Abbott Laboratories、 Roche、 Siemens.
Related Reports
Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Diabetes Testing Program market size was US$ 2674 million in 2025 and is forecast to reach a readjusted size of US$ 4414 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 105
USD 4250.00
(Single User License)
Global Diabetes Testing Program Market Research Report 2026
The global Diabetes Testing Program market was valued at US$ 2674 million in 2025 and is anticipated to reach US$ 4414 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 126
USD 2900.00
(Single User License)
Diabetes Testing Program - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Testing Program was estimated to be worth US$ 2674 million in 2025 and is projected to reach US$ 4414 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 137
USD 3950.00
(Single User License)
Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetes Testing Program market size was US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 104
USD 4250.00
(Single User License)
Global Diabetes Testing Program Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diabetes Testing Program market is projected to grow from US$ 2504 million in 2024 to US$ 4134 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 152
USD 4900.00
(Single User License)
Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetes Testing Program was estimated to be worth US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 129
USD 3950.00
(Single User License)
Global Diabetes Testing Program Market Research Report 2025
The global market for Diabetes Testing Program was valued at US$ 2504 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-01-19
Pages: 92
USD 2900.00
(Single User License)
Global and United States Diabetes Testing Program Market Report & Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 122
USD 4350.00
(Single User License)
Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 125
USD 3950.00
(Single User License)
Global Diabetes Testing Program Market Research Report 2024
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 99
USD 2900.00
(Single User License)
Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Diabetes Testing Program market size was US$ 2674 million in 2025 and is forecast to reach a readjusted size of US$ 4414 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 105
USD 4250.00 (Single User License)Global Diabetes Testing Program Market Research Report 2026
The global Diabetes Testing Program market was valued at US$ 2674 million in 2025 and is anticipated to reach US$ 4414 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 126
USD 2900.00 (Single User License)Diabetes Testing Program - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Testing Program was estimated to be worth US$ 2674 million in 2025 and is projected to reach US$ 4414 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 137
USD 3950.00 (Single User License)Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetes Testing Program market size was US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 104
USD 4250.00 (Single User License)Global Diabetes Testing Program Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diabetes Testing Program market is projected to grow from US$ 2504 million in 2024 to US$ 4134 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 152
USD 4900.00 (Single User License)Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetes Testing Program was estimated to be worth US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 129
USD 3950.00 (Single User License)Global Diabetes Testing Program Market Research Report 2025
The global market for Diabetes Testing Program was valued at US$ 2504 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-01-19
Pages: 92
USD 2900.00 (Single User License)Global and United States Diabetes Testing Program Market Report & Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 122
USD 4350.00 (Single User License)Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 125
USD 3950.00 (Single User License)Global Diabetes Testing Program Market Research Report 2024
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 99
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now